Matrix metalloproteinases and their gene polymorphism in young ST-segment elevation myocardial infarction.

doi:10.1016/j.ihj.2022.11.001

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Matrix metalloproteinases and their gene polymorphism in young ST-segment elevation myocardial infarction.

Indian heart journal - 1 Jan 2000

Basia Deepak, Gupta Mohit Dayal, Kunal Shekhar, Muheeb Ghazi, Girish M P, Bansal Ankit, Batra Vishal, Yusuf Jamal, Mukhopadhyay Saibal, Tyagi Sanjay, Singh Ritu

Abstract excerpt

BACKGROUND: Genetic polymorphism in MMPs are associated with multiple adverse CV events. There is little evidence regarding role of MMPs and their genetic polymorphisms in young (<50 years) ST-segment elevation myocardial infarction (STEMI) patients. METHODS: This study included 100 young (18-50 years) STEMI patients and 100 healthy controls. Serum levels of MMP-3, MMP-9 and TIMP were estimated for both patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Matrix Metalloproteinase 3

Share to Matrix Metalloproteinase 9

Share to Polymorphism, Genetic

Share to Protease and Inhibitor Mechanisms

Share to Tissue Inhibitor of Metalloproteinases

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 36370803
DOI: 10.1016/j.ihj.2022.11.001
PMCID: PMC9773251

Provenance

PubMed metadata and Literature Corpus relationships.